Published in JAMA on October 09, 2002
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med (2010) 2.93
The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma. JAMA Intern Med (2015) 2.68
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care (2010) 2.05
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med (2004) 2.01
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med (2012) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
Medicare prescription drug coverage: consumer information and preferences. Proc Natl Acad Sci U S A (2006) 1.72
Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. JAMA Intern Med (2015) 1.71
Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med (2008) 1.56
Decrease in urinary incontinence management costs in women enrolled in a clinical trial of weight loss to treat urinary incontinence. Obstet Gynecol (2012) 1.45
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ (2005) 1.42
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Drug licenses: a new model for pharmaceutical pricing. Health Aff (Millwood) (2008) 1.39
Urinary incontinence management costs are reduced following Burch or sling surgery for stress incontinence. Am J Obstet Gynecol (2014) 1.39
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children. Arch Gen Psychiatry (2005) 1.30
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health (2008) 1.20
Generic drug prescribing in central Saudi Arabia: perceptions and attitudes of physicians. Ann Saudi Med (2009) 1.14
High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet Gynecol (2008) 1.08
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther (2012) 1.07
Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries. Health Serv Res (2008) 1.06
Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease. Prev Chronic Dis (2006) 1.02
Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med (2013) 0.98
Pharmacy utilization and the Medicare Modernization Act. Milbank Q (2005) 0.98
Pharmaceutical cost management and access to psychotropic drugs: the U.S. context. Int J Law Psychiatry (2005) 0.93
[Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients]. Wien Klin Wochenschr (2008) 0.92
Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care (2011) 0.91
Pharmacy benefit plans and prescription drug spending. JAMA (2002) 0.89
The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees. Health Serv Res (2007) 0.89
Receipt of high risk medications among elderly enrollees in Medicare Advantage plans. J Gen Intern Med (2012) 0.88
A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development. PLoS One (2014) 0.87
Does reimportation reduce price differences for prescription drugs? Lessons from the European Union. Health Serv Res (2008) 0.87
Use of antihypertensive medications and diagnostic tests among privately insured adolescents and young adults with primary versus secondary hypertension. J Adolesc Health (2014) 0.86
Does medication adherence following a copayment increase differ by disease burden? Health Serv Res (2011) 0.86
Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes. J Am Geriatr Soc (2014) 0.84
Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications. Health Serv Res (2012) 0.83
Factors that influence patient response to requests to change to a unified restrictive formulary. J Gen Intern Med (2004) 0.81
Demand for prescription drugs under non-linear pricing in Medicare Part D. Int J Health Care Finance Econ (2013) 0.81
Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006. J Am Heart Assoc (2016) 0.80
An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.79
Did Medicare Part D reduce disparities? Am J Manag Care (2015) 0.79
Prescription drug coverage and effects on drug expenditures among elderly Medicare beneficiaries. Health Serv Res (2008) 0.77
The Impact of Health Insurance Policy Changes on Californians with Severe Chronic Disease. Calif J Politics Policy (2011) 0.75
The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada. Healthc Policy (2015) 0.75
Access to oral osteoporosis drugs among female Medicare Part D beneficiaries. Womens Health Issues (2014) 0.75
Financial consequences of drug benefit plans. JAMA (2003) 0.75
Financial consequences of drug benefit plans. JAMA (2003) 0.75
The financial burden of out-of-pocket expenses in the United States and Canada: How different is the United States? SAGE Open Med (2016) 0.75
Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D. Health Serv Res (2013) 0.75
Systematic review on quality control for drug management programs: is quality reported in the literature? BMC Health Serv Res (2009) 0.75
Is cost-related non-collection of prescriptions associated with a reduction in health? Findings from a large-scale longitudinal study of New Zealand adults. BMJ Open (2015) 0.75
Financial consequences of drug benefit plans. JAMA (2003) 0.75
Trends in pharmaceutical expenditures: the impact on drug benefit design. Am Health Drug Benefits (2008) 0.75
Medication Nonadherence: The Role of Cost, Community, and Individual Factors. Health Serv Res (2016) 0.75
Cost implications of reduced work hours and workloads for resident physicians. N Engl J Med (2009) 6.42
Pharmacy benefits and the use of drugs by the chronically ill. JAMA (2004) 5.56
Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol (2003) 4.77
Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) (2012) 4.36
Forecasting the nursing home population. Med Care (2003) 3.11
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med (2010) 2.93
Neighborhood socioeconomic status and fruit and vegetable intake among whites, blacks, and Mexican Americans in the United States. Am J Clin Nutr (2008) 2.92
Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes (2009) 2.80
Immigrants and health care: sources of vulnerability. Health Aff (Millwood) (2007) 2.78
Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved (2002) 2.75
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
How much is postacute care use affected by its availability? Health Serv Res (2005) 2.60
Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res (2004) 2.50
The Women's Health Initiative: The food environment, neighborhood socioeconomic status, BMI, and blood pressure. Obesity (Silver Spring) (2011) 2.50
Medicare's bundled payment pilot for acute and postacute care: analysis and recommendations on where to begin. Health Aff (Millwood) (2011) 2.39
Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries. N Engl J Med (2002) 2.22
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) (2012) 2.16
Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ (2013) 2.04
Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) (2013) 2.03
Medicare spending and outcomes after postacute care for stroke and hip fracture. Med Care (2010) 1.99
Review: immigrants and health care access, quality, and cost. Med Care Res Rev (2009) 1.98
The role of product design in consumers' choices in the individual insurance market. Health Serv Res (2007) 1.98
Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q (2009) 1.89
Neighbourhood socioeconomic status and biological 'wear and tear' in a nationally representative sample of US adults. J Epidemiol Community Health (2009) 1.89
Are the young becoming more disabled? Health Aff (Millwood) (2004) 1.88
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med (2012) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
Neighborhood context and ethnicity differences in body mass index: a multilevel analysis using the NHANES III survey (1988-1994). Econ Hum Biol (2007) 1.82
The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) (2005) 1.79
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood) (2011) 1.71
Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Ann Intern Med (2013) 1.69
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol (2008) 1.68
Developing predictive models of health literacy. J Gen Intern Med (2009) 1.66
Use of geocoding in managed care settings to identify quality disparities. Health Aff (Millwood) (2005) 1.52
Impact of specialty drugs on the use of other medical services. Am J Manag Care (2008) 1.51
Dialysis practices that distinguish facilities with below- versus above-expected mortality. Clin J Am Soc Nephrol (2010) 1.50
Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences. Health Serv Res (2007) 1.50
Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) (2013) 1.50
U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood) (2008) 1.47
Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system. J Health Econ (2008) 1.45
Predictors for medical students entering a general surgery residency: National survey results. Surgery (2004) 1.43
Family structure and childhood obesity, Early Childhood Longitudinal Study - Kindergarten Cohort. Prev Chronic Dis (2010) 1.42
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood) (2012) 1.38
Patterns of care for open-angle glaucoma in managed care. Arch Ophthalmol (2003) 1.28
Pharmacy benefit caps and the chronically ill. Health Aff (Millwood) (2007) 1.28
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Impact of managed care on the treatment, costs, and outcomes of fee-for-service Medicare patients with acute myocardial infarction. Health Serv Res (2004) 1.27
Disability and health care spending among medicare beneficiaries. Health Aff (Millwood) (2005) 1.26
Updated variable-radius measures of hospital competition. Health Serv Res (2004) 1.26
Effects of payment changes on trends in post-acute care. Health Serv Res (2009) 1.26
Language access services for Latinos with limited English proficiency: lessons learned from Hablamos Juntos. J Gen Intern Med (2007) 1.24
The lifetime burden of chronic disease among the elderly. Health Aff (Millwood) (2005) 1.23
HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood) (2014) 1.21
Recent trends and geographic variation in the safety net. Med Care (2004) 1.20
Community demographics and access to health care among U.S. Hispanics. Health Serv Res (2009) 1.17
Health care markets, the safety net, and utilization of care among the uninsured. Health Serv Res (2007) 1.15
An economic evaluation of the war on cancer. J Health Econ (2010) 1.13
The promise of health care cost containment. Health Aff (Millwood) (2007) 1.13
The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood) (2008) 1.13
Trends and variability in individual insurance products in California. Health Aff (Millwood) (2004) 1.12
Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans? Womens Health Issues (2007) 1.11
Residency work-hours reform. A cost analysis including preventable adverse events. J Gen Intern Med (2005) 1.10
Undiagnosed disease, especially diabetes, casts doubt on some of reported health 'advantage' of recent Mexican immigrants. Health Aff (Millwood) (2012) 1.08
Neighborhood disadvantage and ischemic stroke: the Cardiovascular Health Study (CHS). Stroke (2011) 1.07
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther (2012) 1.07
Cost implications of ACGME's 2011 changes to resident duty hours and the training environment. J Gen Intern Med (2011) 1.06
Initial practice locations of international medical graduates. Health Serv Res (2002) 1.05
Identifying best practices in dialysis care: results of cognitive interviews and a national survey of dialysis providers. Clin J Am Soc Nephrol (2008) 1.04
Dimensions of the local health care environment and use of care by uninsured children in rural and urban areas. Pediatrics (2006) 1.04
Family structure and the treatment of childhood asthma. Med Care (2008) 1.03
The effect of prospective payment on admission and treatment policy: evidence from inpatient rehabilitation facilities. J Health Econ (2013) 1.02
Hospital competition, managed care, and mortality after hospitalization for medical conditions in California. Health Serv Res (2007) 1.02
English language proficiency and geographical proximity to a safety net clinic as a predictor of health care access. J Immigr Minor Health (2011) 1.01
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood) (2012) 1.01
Digesting the doughnut hole. J Health Econ (2013) 1.00
Sociodemographic differences in use of preventive services by women enrolled in Medicare+Choice plans. Prev Med (2004) 0.99
Medicare Part D: a successful start with room for improvement. JAMA (2008) 0.99
Medicare part D after 2 years. Am J Manag Care (2009) 0.99
Medicare payment reform and provider entry and exit in the post-acute care market. Health Serv Res (2013) 0.97
The Disability burden of COPD. COPD (2012) 0.97
Quantifying income-related inequality in healthcare delivery in the United States. Med Care (2004) 0.97
Primary non-adherence of medications: lifting the veil on prescription-filling behaviors. J Gen Intern Med (2010) 0.97
Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care (2013) 0.97
Employer-sponsored insurance, health care cost growth, and the economic performance of U.S. Industries. Health Serv Res (2009) 0.96
How costly is hospital quality? A revealed-preference approach. J Ind Econ (2011) 0.96
Identifying potential health care innovations for the future elderly. Health Aff (Millwood) (2005) 0.96
The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int (2009) 0.93
Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey. Clin J Am Soc Nephrol (2009) 0.93
Spending and mortality in US acute care hospitals. Am J Manag Care (2013) 0.93
The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography (2010) 0.93
The prospect of a generation free of HIV may be within reach if the right policy decisions are made. Health Aff (Millwood) (2014) 0.92
Predictors of surgery resident satisfaction with teaching by attendings: a national survey. Ann Surg (2005) 0.92
Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care (2011) 0.91
Is the individual market more than a bridge market? An analysis of disenrollment decisions. Inquiry (2006) 0.90
Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. Health Aff (Millwood) (2014) 0.90
Neighborhood archetypes for population health research: is there no place like home? Health Place (2010) 0.90